2Moragoda L, Ja Szewski R, Kulrani P, et al. Age-associated loss of heterozygosity of tumor suppressor genes in the gastric of humans. Am J Physiol Gastrointest Liver Physiol, 2002, 282:G932-936.
3Huang SP, Wu MS, Shun CT, et al. Tumor angiogenesis increase with nuclear P53 accumulation in gastric carcinoma. Hepatogastroenterology, 2002, 49: 1453-1456.
4Lee HS, Chol SI, Lee HK, et al. Distinct clinical features and outcomes of gastric cancer with micro,satellite instability. Mod Pathol, 2002, 15: 632-640.
5Ming SC. Cellular and molecular pathology of gastric carcinoma and precursor lesions:a critical review. Gastric Cancer, 1998, 1:31-50.
6Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histological classification. Acta Pathol Microbiol Stand, 1965, 64: 31-49.
7Shibata A, Longacre TA, Puligandle B, et al. Histological classification of gastric adenoeareinoma for epidemiological research: concordance between pathologists. Cancer Epidemiol Biomarkers Prev,2001, 10: 75-78.
8Schlemper RJ, Riddell RH, Kato Y, et al.The Vienna classification of gastrointestinal epithelial neoplasia. Gut, 2000, 47: 251-255.
9Pinto-deSousa J, David L, Reis CA, et al.Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinical-biological behaviour of gastric carcinoma. Virchous Arch, 2002, 440: 304-310.
10Torii A, Kodera Y, lto M, et al. Matrix metalloproteinase 9 in mucosally invasive gastric cancer. Gastric Cancer, 1998, 1:142-145.
二级参考文献13
1Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 1986, 46 : 705-716.
2Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell,1996,87: 13-20.
3Mayo MW, Baldwin AS. The transcription factor NF-kappa B:control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta,2000,1470: M55-M62.
4Yoshimura T, Matsushima K, Oppenheim J J, et al. Neutrophil chemotactic factor produced by lipopolysaccharide( LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 ( IL-1 ). J Immunol, 1987, 139 : 788-793.
5Smith DR, Polverini PJ, Kunkel SL, et al. Inhibition of IL-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med,1994,179 : 1409-1415.
6Arenberg DA, Kunkel SL, Polverini PJ, et al. Inhibition of IL-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest, 1996,97 : 2792-2802.
7Luca M, Huang S, Gershenwald JE, et al. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol, 1997, 151:1105-1113.
9Beg APt, Sha WC, Bronson RT, et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature,1995,376: 167-170.
10Inoue K, Slaton JW, Kim SJ, et al. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res,2000,60: 2290-2299.
